EU regulator starts safety review of coronavirus drug
|
October 2, 2020 11:33 AM
LONDON (AP) — The European Medicines Agency says it has started a safety review after some patients taking the coronavirus drug remdesivir reported serious kidney problems.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
